ESMO - European Society for Medical Oncology

👉 Dr. Pawel Sobczuk and Dr. Christopher Oing highlight the value of the ESMO Sarcoma and Rare Cancers Congress 2025 (20–22 March, Lugano, Switzerland) for advancing oncology research and career development. ⏰Late registration available until 19 February—secure your place today! #ESMORareCancers25 🔗 https://ow.ly/xOxz50UTRSb

📣 New ESMO–EURACAN #ClinicalPracticeGuideline in #SinonasalMalignancy includes treatment advances in #radiotherapy focusing on #particletherapy and #neoadjuvantchemotherapy in high-grade, locally advanced malignancies. #ESMOGuidelines 🔗 https://ow.ly/SrKU50UUEvN Carlo Resteghini Bertrand Baujat Paolo Bossi Jose Hardillo Mario Hermsen Nicola Alessandro Iacovelli Roberto Maroldi Piero Nicolai Ester Orlandi Juliette Thariat Michiel van den Brekel Carla Van Herpen Emma Kinloch Caroline EVEN

The 2025 ESMO Society Awards nomination process is now open for #ESMOMembers to nominate candidates before 12 March 2025. The ESMO Society Awards recognise excellence in the field of #oncology:    📌ESMO Award, for outstanding contribution to the development of #MedicalOncology 📌ESMO Award for Translational Research, for outstanding results in #TranslationalResearch 📌ESMO Women for Oncology Award, for significant contribution to supporting the #CareerDevelopment of women in #oncology 📌ESMO Lifetime Achievement Award, for a lifelong commitment to clinical #CancerResearch and education If you are interested in nominating someone, check eligibility criteria and submit your nominations now. 👉🏻 https://ow.ly/WpOz50UTORy

📣 Abstract submission for the ESMO Gastrointestinal Cancers Congress 2025 is open! Join us in 📍Barcelona, 2–5 July 2025, to present your work, engage with top experts, and advance GI oncology. 👉Submit your research and help drive innovation! #ESMOGI25 🔗 https://ow.ly/M8to50UTOXy

ESMO Announces the Launch of its globalised Patient Advocates Working Group. The newly globalised Patient Advocates Working Group aims at amplifying the voices of patients worldwide and ensuring that patient perspectives find a place in #OncologyResearch, policy, and practice. 🔗 Read more https://ow.ly/YNFV50UTPiP #PatientAdvocacy #Oncology #CancerCare #GlobalHealth

🚨#ESMO25: The registration system is now open! Join us at an event where multidisciplinary innovation meets global collaboration. ⏰Big savings by registering before 16 July 2025 ➡️ Expand your knowledge with cutting-edge science, practical workshops, and real-world case discussions. ➡️ Connect with leading experts, peers and pioneers in oncology – networking opportunities await onsite and online. ➡️ Join a trusted platform recognized for its contribution to advancing cancer care worldwide. ➡️ From expert insights to career-enhancing workshops, this congress is for everyone aiming at making at impact in the oncology field. 🔗https://ow.ly/8hTG50UTOyw

ESMO is pleased to announce that Philippe Bedard, Professor of Medicine at the University of Toronto, Canada was bestowed the 2025 TAT Honorary Award. He is recognised for his outstanding contributions to early-phase clinical trials with novel cancer drug treatments, including immunotherapy and personalised medicine. 📅 He will deliver his award lecture “Bridging cancer genomics and drug development: An academic perspective” on 3 March 2025, at the #ESMOTAT25 in Paris. Read more📌 https://ow.ly/uYYB50UT75z

📣 #ESMOBreast25: Time is running out, last days to share your research! Join a global platform where your findings could make a crucial impact on the future of breast cancer care. The world is waiting for your insights – don’t miss this chance to drive change in breast cancer treatment and care. ⏰Abstract submission deadline 11 February 2025 Learning objectives: ➡️  Update your knowledge on the fast-developing field of breast cancer ➡️  Understand recent developments in novel diagnostics, biomarkers, and treatments among the different subtypes of breast cancer ➡️  Gain insights on risk-adapted strategies for optimising treatment of breast cancer ➡️  Receive updates on the impact of antibody drug conjugates and immunotherapy on treatment landscape for breast cancer ➡️  Understand special considerations for different subgroups of patients with breast cancer 🔗https://ow.ly/v6hT50USbrl

🌍 This #WorldCancerDay (WCD), ESMO stands with the global community in our shared commitment to delivering the best possible care to people with cancer. 🤝 As part of #WCD ’s #UnitedByUnique campaign, ESMO acknowledges that every person’s experience with cancer is unique. Ensuring optimal cancer treatment and care remains a priority: today, like every day, we reaffirm our commitment to the #ONEoncologycommunity providing the education, the training, and the scientific innovation needed to best serve patients with #cancer. Together, we continue to advance cancer care worldwide. #WorldCancerDay #UnitedByUnique fabrice andre

🌍ESMO is honoured to contribute to global health policymaking at the 156th WHO Executive Board Meeting (3–11 February 2025). As a Non-State Actor in official relations with @WHO, we will deliver statements addressing issues critical to medical oncologists, cancer patients and their caregivers, including: ✅Ensuring continuity of care during emergencies ✅Combating air pollution for better health ✅Enhancing access to cancer care globally ✅Supporting the oncology workforce to prevent burnout ✅Action on rare cancers to advance Universal Health Coverage (UHC) ESMO’s participation underscores its commitment to shaping health policies that improve access to optimal cancer care worldwide. 👉 Join us in following the discussions and advocating for patients and carers: https://ow.ly/eU5O50UR4bT #GlobalHealth #EB156 #CancerCare